Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for distinguishing ulcerative colitis from Crohn's disease by detecting the presence of fecal anit-neutrophil cytoplasmic antibodies (ANCA)

Method for distinguishing ulcerative colitis from Crohn's disease by detecting the presence of fecal anit-neutrophil cytoplasmic antibodies (ANCA)

US Patent 7736858 · Granted Jun 15, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2016
Nucleic acid extraction using organic solvents to remove inhibitors2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Device and method for detection of analytes2016